EMAIL THIS PAGE TO A FRIEND

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

A Breast Tissue Protein Expression Profile Contributing to Early Parity-Induced Protection Against Breast Cancer.


PMID 26536102

Abstract

Early parity reduces breast cancer risk, whereas, late parity and nulliparity increase breast cancer risk. Despite substantial efforts to understand the protective effects of early parity, the precise molecular circuitry responsible for these changes is not yet fully defined. Here, we have conducted the first study assessing protein expression profiles in normal breast tissue of healthy early parous, late parous, and nulliparous women. Breast tissue biopsies were obtained from 132 healthy parous and nulliparous volunteers. These samples were subjected to global protein expression profiling and immunohistochemistry. GeneSpring and MetaCore bioinformatics analysis software were used to identify protein expression profiles associated with early parity (low risk) versus late/nulliparity (high risk). Early parity reduces expression of key proteins involved in mitogenic signaling pathways in breast tissue through down regulation of EGFR1/3, ESR1, AKT1, ATF, Fos, and SRC. Early parity is also characterized by greater genomic stability and reduced tissue inflammation based on differential expression of aurora kinases, p53, RAD52, BRCA1, MAPKAPK-2, ATF-1, ICAM1, and NF-kappaB compared to late and nulli parity. Early parity reduces basal cell proliferation in breast tissue, which translates to enhanced genomic stability, reduced cellular stress/inflammation, and thus reduced breast cancer risk.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1306395
ANTI-AIK(N-TERMINAL) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB4502887
Anti-AURA, C-Terminal antibody produced in rabbit, affinity isolated antibody
HPA002636
Anti-AURKA antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2100190
Anti-AURKA antibody produced in rabbit, affinity isolated antibody
A1231
Anti-Aurora-A Kinase antibody, Mouse monoclonal, clone 35C1, purified from hybridoma cell culture
SAB4300444
Anti-RPS6KB1 (Ab-389) antibody produced in rabbit, affinity isolated antibody
SAB4300515
Anti-RPS6KB1 (Ab-411) antibody produced in rabbit, affinity isolated antibody
SAB4300500
Anti-RPS6KB1 (Ab-421) antibody produced in rabbit, affinity isolated antibody
SAB4300527
Anti-RPS6KB1 (Ab-424) antibody produced in rabbit, affinity isolated antibody
SAB1412617
ANTI-RPS6KB1 antibody produced in mouse, clone 2C2, purified immunoglobulin, buffered aqueous solution
SAB1412626
ANTI-RPS6KB1 antibody produced in mouse, clone 4H4, purified immunoglobulin, buffered aqueous solution
SAB2104784
Anti-RPS6KB1, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB2104785
Anti-RPS6KB1, (N-terminal) antibody produced in rabbit, affinity isolated antibody
S4047 Anti-S6 Kinase antibody produced in rabbit, whole antiserum
SAB4502691
Anti-S6K antibody produced in rabbit, affinity isolated antibody
SAB5300335 Monoclonal Anti-AURKA antibody produced in mouse, clone 1F8, ascites fluid
SAB5300336 Monoclonal Anti-AURKA antibody produced in mouse, clone 4G10, ascites fluid
SAB1404335
Monoclonal Anti-RPS6KB1, (C-terminal) antibody produced in mouse, clone 1E10, purified immunoglobulin, buffered aqueous solution
WH0006790M1
Monoclonal Anti-STK6 antibody produced in mouse, clone 5F8, purified immunoglobulin, buffered aqueous solution